Phase 1 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People older than 6 months of age.
- People whose bone marrow sample shows a high number of abnormal (cancer) cells — at least 30% — which is needed for certain laboratory testing and treatment preparation.
- People whose cancer cells show certain specific proteins on their surface (such as CD7, CD5, CD317, CD47, CD99, CD38, or TRBC1/2), as detected by laboratory testing.
- People who are in reasonably good general health, as measured by a standard health scoring system, and whose life expectancy is greater than 3 months.
- People whose heart, liver, kidneys, and bone marrow are functioning well enough to meet specific laboratory test thresholds — including heart pumping function of at least 50%, blood oxygen level of at least 90%, and kidney and liver values within acceptable ranges.
- People whose blood haemoglobin (a measure of red blood cell health) is at an acceptable level (at least 80g/L).
- People who have no medical reasons preventing a cell separation procedure.
- People who are able to understand the study and are willing to sign a written consent form.
Who may not be able to join:
- People with a serious illness or medical condition that would make it unsafe to follow the trial procedures, including those with an active infection that is not under control.
- People with an active bacterial, fungal, or viral infection that has not been controlled with treatment.
- People with a known diagnosis of HIV, hepatitis B, or hepatitis C.
- People who are pregnant or breastfeeding.
- People who have used steroid (glucocorticoid) medications as a whole-body (systemic) treatment within the week before entering the trial.
- People who have previously received any gene therapy treatment.
- People who the trial investigators believe may not be suitable or may not be able to follow the trial requirements (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 0755-86573763
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Treatment-related adverse events are assessed by NCI CTCAE V4.0 criteria.; Clinical response; Evaluate the percentage of minimal leukemia residue in bone marrow
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.